Research & Program News
The results of a landmark trial conducted in part at the Memory and Aging Program at Butler Hospital show that amyloid PET brain scan imaging significantly improves both the accuracy of diagnosis and the subsequent medical management of patients with mild cognitive impairment and dementia.
Memory and Aging Program Director Dr. Stephen Salloway, a study co-author, calls the findings a “game changer” in Alzheimer’s research.
The world’s first participant in an Alzheimer’s prevention study finished his 4 1/2-year clinical trial last month. Here’s what he has to say about the experience.
Major advances in the fight against Alzheimer's disease are on the horizon thanks to increasing support for research in recent years. An inspiring example of that support was on display locally on Saturday, November 10, when hundreds of people turned out...
This new study is currently enrolling people aged 40 – 64 with normal memory or early onset cognitive impairment. The goal is to better understand how and why some people develop this rare form of Alzheimer’s disease.